Cleveland (WJW) – It has a new weapon in America’s fight against obesity with FDA approval of a new drug on Friday.
Dr. W. Scott Butsch, director of obesity medicine at the Cleveland Clinic’s Bariatric and Metabolic Institute, said he was excited by the news.
Butsch said, “I think we have to understand that obesity is a chronic disease and we have to take it seriously.”
Wegovy is a higher-dose semalutide.
“This drug mimics hormones that come from the digestive tract. especially the cells in our intestines And it has the ability to send signals to the brain and to send satiety signals to the brain,” Butsch said.
He says it also slows down the stomach and helps insulin work better at regulating blood sugar.
“The study population lost more than 15% of their body weight and one in three patients lost more than 20% of their body weight, which is clearly more than any other obesity drug. twice as many on the market today.”
The study was conducted over 16 months.
“It can cause most gastrointestinal side effects. And that could be nausea, vomiting, diarrhea,” Butch said about the main side effects.
Wegovy was the first chronic weight management drug approved since 2014.
Butsch said: “I think this is a new class of drugs that show really impressive efficacy and safety data. and will be released in the market in the years to come.”
Butsch said he hopes the study and approval will remove the stigma of more than 40 percent of U.S. adults who are obese.
“Not because they are eating fries. It’s not because they’re sitting on the couch in front of the TV,” Butch said. “It’s because there’s a very normal regulatory disorder that builds up in our entire body to regulate our body fat.”
He said there are still financial barriers to proper obesity care.
“In this and other states in the country few insurance companies believe that obesity is a chronic disease. thus covering adequate and appropriate obesity options,” the doctor said.
Butsch hopes the approval will encourage people to tackle their weight problems and providers to take obesity seriously.
Butsch says: “For many people, these drugs can be game-changers and cause weight loss.
Wegovy is injected once a week. Doctors say losing up to 5 percent of your body weight can boost your energy. and lower blood pressure blood sugar and cholesterol levels
To learn more about Wegovy’s FDA approval, click here.